CEBPDamplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis
Open Access
- 17 August 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (31) , 31069-31084
Abstract
CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosisKeywords
This publication has 50 references indexed in Scilit:
- Epithelial Membrane Protein 2 Is a Prognostic Indictor for Patients with Urothelial Carcinoma of the Upper Urinary TractThe American Journal of Pathology, 2013
- CCAAT/Enhancer-binding Protein δ Mediates Tumor Necrosis Factor α-induced Aurora Kinase C Transcription and Promotes Genomic InstabilityJournal of Biological Chemistry, 2011
- Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladderBMC Medical Genomics, 2010
- The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasisThe EMBO Journal, 2010
- Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cellsBiochemical Pharmacology, 2010
- Function of C/EBPδ in a regulatory circuit that discriminates between transient and persistent TLR4-induced signalsNature Immunology, 2009
- Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase ComplexJournal of Biological Chemistry, 2008
- Reciprocal regulation of p63 by C/EBP delta in human keratinocytesBMC Molecular Biology, 2007
- Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?Carcinogenesis, 2005
- Promoter methylation reduces C/EBPδ (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumorsBreast Cancer Research and Treatment, 2005